Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.485 USD | +3.72% | +19.56% | +51.51% |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Mar. 19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.51% | 411M | |
-1.74% | 103B | |
+7.38% | 101B | |
+4.40% | 23.07B | |
-11.97% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.72% | 16.94B | |
+6.32% | 14.07B | |
+38.03% | 12.35B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5